These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 11657776)

  • 1. Research compliance changes will affect rules on protection of human subjects.
    Maloney DM
    Hum Res Rep; 1999 May; 14(5):1-2. PubMed ID: 11657776
    [No Abstract]   [Full Text] [Related]  

  • 2. Federal report says protection of human subjects is threatened by numerous factors.
    Maloney DM
    Hum Res Rep; 1996 May; 11(5):1-3. PubMed ID: 11654438
    [No Abstract]   [Full Text] [Related]  

  • 3. Exempt research: procedures in the intramural research program of the National Institutes of Health.
    Wichman A; Mills D; Sandler AL
    IRB; 1996; 18(2):3-5. PubMed ID: 11654755
    [No Abstract]   [Full Text] [Related]  

  • 4. The concept of the IRB and bureaucratic reality: an exchange of letters.
    van Eys J; Levine RJ
    IRB; 1984; 6(4):8-10. PubMed ID: 11649563
    [No Abstract]   [Full Text] [Related]  

  • 5. The Food and Drug Administration's role in the protection of human subjects.
    Nightingale SL
    IRB; 1983; 5(1):6-9. PubMed ID: 11649511
    [No Abstract]   [Full Text] [Related]  

  • 6. Half-full or half-empty? Evaluating IRB performance.
    Mishkin B; Ariand N
    Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
    [No Abstract]   [Full Text] [Related]  

  • 7. Two rules on expedited IRB reviews are final.
    Maloney DM
    Hum Res Rep; 1999 Jan; 14(1):3. PubMed ID: 11657557
    [No Abstract]   [Full Text] [Related]  

  • 8. Ethical issues in clinical neurological research.
    Shore D; Berg K; Mullican C
    J Calif Alliance Ment Ill; 1994; 5(1):61-2. PubMed ID: 11653329
    [No Abstract]   [Full Text] [Related]  

  • 9. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
    Weijer C
    IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
    [No Abstract]   [Full Text] [Related]  

  • 10. The regulation of human experimentation in the United States--a personal odyssey.
    Katz J
    IRB; 1987; 9(1):1-6. PubMed ID: 11649890
    [No Abstract]   [Full Text] [Related]  

  • 11. Special informed consent requirements are included in protocol review procedures.
    Maloney DM
    Hum Res Rep; 1995 Jul; 10(7):1-2. PubMed ID: 11654274
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal investigation concludes that institutional review boards are in trouble.
    Maloney DM
    Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
    [No Abstract]   [Full Text] [Related]  

  • 13. OPRR and FDA propose revised expedited review categories.
    McGough H
    IRB; 1998; 20(1):9, 11. PubMed ID: 11655326
    [No Abstract]   [Full Text] [Related]  

  • 14. New policy on research with children is part of trend toward including more research subjects.
    Maloney DM
    Hum Res Rep; 1998 May; 13(5):1-2. PubMed ID: 11657189
    [No Abstract]   [Full Text] [Related]  

  • 15. The history of institutional review boards.
    Sherman M; Van Vleet JD
    Regul Aff J; 1991; 3():615-27. PubMed ID: 11651491
    [No Abstract]   [Full Text] [Related]  

  • 16. An overview of FDA, IRBs and regulations.
    Petricciani JC
    IRB; 1981 Dec; 3(10):1-3, 11. PubMed ID: 11649413
    [No Abstract]   [Full Text] [Related]  

  • 17. Institutional animal care and use committees.
    Britt DP
    ATLA Abstr; 1986 Mar; 13(3):236-9. PubMed ID: 11649839
    [No Abstract]   [Full Text] [Related]  

  • 18. Federal agency keeps review committee after public comments support continuation.
    Maloney DM
    Hum Res Rep; 1997 Jan; 12(1):1-2. PubMed ID: 11654603
    [No Abstract]   [Full Text] [Related]  

  • 19. Review panel cancels meeting as gene therapy proposals fall.
    Wadman M
    Nature; 1996 Feb; 379(6567):668. PubMed ID: 11644770
    [No Abstract]   [Full Text] [Related]  

  • 20. Toward a more comprehensive approach to protecting human subjects: the interface of data safety monitoring boards and institutional review boards in randomized clinical trials.
    Gordon VM; Sugarman J; Kass N
    IRB; 1998; 20(1):1-5. PubMed ID: 11655324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.